COLOGNE, Germany and BANGALORE, India, August 4, 2010 /PRNewswire/ -- TUV Rheinland has opened its seventh laboratory worldwide in Electronics City in the Indian city of Bangalore for testing solar modules and systems. The world leader in independent safety and quality testing for solar modules has invested EUR2 million in the new solar test centre, which in particular will offer services to India's growing solar industry. In this way, TUV Rheinland is filling a significant gap for Indian industry, which previously did not have access to large test facilities on such a scale. The test centre has 2,000 square metres of space, including an outside test field of 500 square metres, with equipment such as five climate chambers and two sun simulators. This makes it the most up to date and largest laboratory in the entire South Asian economic area.
"Our investment programme for the solar industry aims to place our services within easy reach of companies in and for all booming markets and to offer them large test capacities. India cannot be neglected here. In addition, all our customers can call upon the decades of expertise gained by our now 180 experts around the world to test and certify systems, modules and components", declared Friedrich Hecker, CEO of TUV Rheinland AG. This is made possible by the extremely close interlinking of all seven of TUV Rheinland's test laboratories. This goes for both photovoltaics and solar thermal technology.
The new test centre is located in Electronics City - which, with around
160,000 employees in over 120 companies, is the hub of
SOURCE TUV Rheinland AG
Copyright©2010 PR Newswire.
All rights reserved
Related biology technology :
1. Genedata Announces Five-Year Agreement Extension with Kluyver Centre for Genomics of Industrial Fermentation
2. Merck Engages PharmaVentures to Assist in the Divestment of its Italian Research Centre IRBM
3. The NIHR Biomedical Research Centre for Mental Health London has Joined the MetaMiner CNS Partnership Program
4. News Release: Homeland Security to Take Centre Stage with Global Security Asia 2009
5. Canadas Genome Centres Promote Collaboration at International Conference
6. Mayuka Labs R&D Centre Gets DSIR Recognition
7. YM BIOSCIENCES NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE
8. New nanotechnology centre helps turn big ideas into real products
9. Simbionix Continues its Global Expansion
10. O2h Continues to Support Senexis to Support Patent Filing Senexis Limited
11. Regado Biosciences, Inc. Continues to Expand Its Patent Portfolio By Announcing Issuance of a New Patent for Its Product Candidates, the REG1 and REG2 Anticoagulation Systems